
Aardvark Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Aardvark Therapeutics Inc is a U.S.-based biotechnology company focused on the development of small molecule therapeutics for the treatment of metabolic and inflammatory diseases. The company engages in research and clinical development aimed at modulating specific biological pathways to address unmet medical needs. Aardvark Therapeutics operates through internal R&D efforts and collaborations with academic and industry partners. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
AARD
Country
🇺🇸 United States